FA

Frédéric Allain

Prof. Frédéric Allain is an expert in the role of RNA in disease, using NMR technology to elucidate the structure of protein-RNA complexes. He and his research team use biophysical tools to study protein RNA interactions, with a focus on the notable segment of genetic diseases that originate from a post-transcriptional mis-regulation of gene expression often caused by splicing, RNA editing or translation defects. Prof. Allain is a specialist in investigating the molecular mechanism in drug development programs for Spinal Muscular Atrophy (SMA), Myotonic Dystrophy (DM) and Amyotrophic Lateral Sclerosis (ALS). He received his Ph.D. from Cambridge University, U.K.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Skyhawk Therapeutics

1 followers

At Skyhawk Therapeutics we invent small molecules using proprietary kinetic, structural and computational models that correct RNA splicing and mis-spicing. Our small molecule platform accelerates drug development across a broad range of disease types.


Industries

Employees

51-200

Links